# US 2018/0021501 A1 · Peritoneal dialysate preparation and sensor system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021501 A1
- Document ID: US20180021501A1
- Status: Published application
- Kind: A1
- Application number: 15/723,676
- Filed: 2017-10-03
- Published: 2018-01-25
- Earliest claimed: 2016-04-04
- Assignees: Medtronic, Inc.
- Applicants: Medtronic, Inc.
- Inventors: Martin T. Gerber; Christopher M. Hobot; David B. Lura; Thomas E. Meyer; VenKatesh R. Manda
- Web page: https://patentgrep.com/patent/US20180021501A1

## CPC

- A61M 1/287: {Dialysates therefor}
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/7004: Monosaccharides having only carbon, hydrogen and oxygen atoms
- A61K 33/10: Carbonates; Bicarbonates
- A61K 33/14: Alkali metal chlorides; Alkaline earth metal chlorides
- A61L 2/10: Ultraviolet [UV] radiation
- A61M 1/1656: {Apparatus for preparing dialysates}
- A61M 1/1672: {using membrane filters, e.g. for sterilising the dialysate}
- A61M 1/1674: {using UV radiation sources for sterilising the dialysate}
- A61M 1/1686: {by heat}
- A61M 1/28: Peritoneal dialysis {; Other peritoneal treatment, e.g. oxygenation}
- C02F 1/283: {using coal, charred products, or inorganic mixtures containing them}
- C02F 1/325: {Irradiation devices or lamp constructions}
- C02F 1/42: by ion-exchange (ion-exchange in general B01J)
- C02F 1/441: {by reverse osmosis}
- C02F 1/442: {by nanofiltration}
- C02F 1/444: {by ultrafiltration or microfiltration}
- A61M 1/1666: {by dissolving solids}
- A61M 2205/18: with alarm
- A61M 2205/3306: Optical measuring means
- A61M 2205/3317: Electromagnetic, inductive or dielectric measuring means
- A61M 2205/3324: PH measuring means
- A61M 2205/3331: Pressure; Flow
- A61M 2205/3334: Measuring or controlling the flow rate
- A61M 2205/3337: Controlling, regulating pressure or flow by means of a valve by-passing a pump
- A61M 2205/3368: Temperature
- A61M 2205/36: related to heating or cooling
- A61M 2205/502: User interfaces, e.g. screens or keyboards
- A61M 2205/75: with filters
- A61M 2205/7518: bacterial
- A61M 2205/7545: for solid matter, e.g. microaggregates
- A61M 2209/084: Supporting bases, stands for equipment
- C02F 2303/04: Disinfection
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C02F: TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE (separation in general B01D; special arrangements on waterborne vessels of installations for treating water, waste water or sewage, e.g. for producing fresh water, B63J; adding materials to water to prevent corrosion C23F; treating radioactively-contaminated liquids G21F9/04; regeneration of reactants for recirculation into processes, see the relevant places for the processes)

## Abstract

The invention relates to devices, systems, and methods for generating a peritoneal dialysate having specified concentrations of one or more solutes. The devices, systems and methods use conductivity sensors, flow meters, and composition sensors to control addition of osmotic agents and ion concentrates into a peritoneal dialysate generation flow path.

## Claims

### Claim 1

A dialysate preparation system for use in peritoneal dialysis, comprising:
a first fluid line fluidly connected to a water purification module;
at least one ion concentrate source fluidly connected to the first fluid line through a first infusate line; the first infusate line having a first concentrate pump;
one or more osmotic agent sources fluidly connected to the first fluid line through one or more secondary infusate lines; the secondary infusate lines comprising a secondary concentrate pump forming part of the one or more secondary infusates lines;
wherein at least one or more conductivity sensors are positioned in the first fluid line upstream of the first infusate line; at least one or more secondary conductivity sensors are positioned in the first fluid line downstream of the first infusate line and upstream of the secondary infusate lines; and at least one composition sensor positioned in the first fluid line downstream of the one or more secondary infusate lines;
the first fluid line fluidly connectable to an integrated cycler.

### Claim 2 (depends on 1)

The dialysate preparation system of claim 1, further comprising at least one secondary composition sensor positioned in the one or more secondary infusate lines.

### Claim 3 (depends on 2)

The dialysate preparation system of claim 2, further comprising a control system in communication with the composition sensor and secondary composition sensor, the control system measuring an osmotic agent concentration at the composition sensor and secondary composition sensor.

### Claim 4 (depends on 3)

The dialysate preparation system of claim 3, the control system controlling an osmotic agent flow rate based on the composition sensor and secondary composition sensor.

### Claim 5 (depends on 1)

The dialysate preparation system of claim 1, further comprising at least one flow meter in the first fluid line.

### Claim 6 (depends on 1)

The dialysate preparation system of claim 1, wherein at least two osmotic agent sources are fluidly connected to the one or more secondary infusate lines.

### Claim 7 (depends on 6)

The dialysate preparation system of claim 6, further comprising one or more valves fluidly connecting the at least two osmotic agent sources to the secondary infusate line.

### Claim 8 (depends on 1)

The dialysate preparation system of claim 1, further comprising a control system in communication with the conductivity sensor and secondary conductivity sensor, the control system controlling an ion concentrate flow rate based on the conductivity sensor and secondary conductivity sensor.

### Claim 9 (depends on 1)

The dialysate preparation system of claim 1, further comprising at least one pH sensor in the first fluid line.

### Claim 10 (depends on 2)

The dialysate preparation system of claim 2, wherein the composition sensor and/or secondary composition sensor are selected from the group consisting of a refractive index sensor, an enzyme-based sensor, and a pulsed amperometric detection sensor.

### Claim 11 (depends on 1)

The dialysate preparation system of claim 1, further comprising a second fluid line fluidly connecting the secondary infusate line to a sterilization module.

### Claim 12

A method of generating a peritoneal dialysate, comprising:
a) pumping water from a water source through a water purification module into a first fluid line;
b) measuring a first conductivity of fluid in the first fluid line;
c) pumping an ion concentrate from at least one ion concentrate source through a first infusate line into the first fluid line;
d) measuring a second conductivity of the fluid in the first fluid line downstream of the first infusate line;
e) pumping an osmotic agent concentrate from an osmotic agent source through a second infusate line into the first fluid line;
f) measuring a first osmotic agent concentration in the first fluid line downstream of the second infusate line.

### Claim 13 (depends on 12)

The method of claim 12, further comprising the step of measuring a second osmotic agent concentration in the second infusate line.

### Claim 14 (depends on 12)

The method of claim 12, further comprising the steps of pumping fluid from the first fluid line into a sterilization module and pumping the fluid from the sterilization module into an integrated cycler.

### Claim 15 (depends on 12)

The method of claim 12, further comprising receiving a dialysate prescription; and setting an ion concentrate flow rate and an osmotic agent flow rate based on the dialysate prescription.

### Claim 16 (depends on 13)

The method of claim 13 wherein the step of setting an ion concentrate flow rate and an osmotic agent flow rate is performed by a control system in communication with a first concentrate pump in the first infusate line and a second concentrate pump in the second infusate line.

### Claim 17 (depends on 16)

The method of claim 16, wherein the control system sets the osmotic agent flow rate based on the first osmotic agent concentration and the dialysate prescription.

### Claim 18 (depends on 15)

The method of claim 15, further comprising the step of generating an alert if the first osmotic agent concentration and/or the second conductivity are outside of a predetermined range from the dialysate prescription.

### Claim 19 (depends on 12)

The method of claim 12, further comprising either or both of:
a) generating the ion concentrate by pumping purified water from a sterilization module into the ion concentrate source; and/or
b) generating the osmotic agent concentrate by pumping purified water from the sterilization module into the osmotic agent source.

### Claim 20 (depends on 19)

The method of claim 19, wherein either or both of:
a) the step of generating the ion concentrate further comprises agitating the ion concentrate after pumping the purified water into the ion concentrate source, heating the purified water prior to pumping the purified water into the ion concentrate source, or combinations thereof; and/or
b) the step of generating the osmotic agent concentrate further comprises agitating the osmotic agent concentrate after pumping the purified water into the osmotic agent source, heating the purified water prior to pumping the purified water into the osmotic agent source, or combinations thereof.
